Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids

Código QR

Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids

Abstract Background Resistance to oxaliplatin is a major obstacle for the management of locally advanced and metastatic colon cancer (CC). Although long noncoding RNAs (lncRNAs) play key roles in CC, the relationships between lncRNAs and resistance to oxaliplatin have been poorly understood yet. Met...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Qingguo Li, Huizhen Sun, Dakui Luo, Lu Gan, Shaobo Mo, Weixing Dai, Lei Liang, Yufei Yang, Midie Xu, Jing Li, Peiyong Zheng, Xinxiang Li, Yan Li, Ziliang Wang
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Lnc-RP11-536 K7.3 Organoid Oxaliplatin Colon cancer Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/8081b82ccf514fbfbfb89fb2a0cf39cc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Descripción y análisis de la Ley sobre Violencia Escolar (N°20.536): dos paradigmas antagónicos
por: Magendzo K,Abraham, et al.
Publicado: (2013)

Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
por: Li Y, et al.
Publicado: (2020)

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
por: Dan Lin, et al.
Publicado: (2021)

Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer
por: Hélène Bellio, et al.
Publicado: (2021)

A Novel Targeted Therapy System for Cervical Cancer:  Co-Delivery System  of  Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier
por: Ye H, et al.
Publicado: (2021)

Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
por: Nicolas Kerckhove, et al.
Publicado: (2021)

Teoría sociológica clásica /
por: Ritzer, George
Publicado: (1993)

Teoría sociológica contemporánea /
por: Ritzer, George
Publicado: (1996)

Improvements in the Oral Absorption and Anticancer Efficacy of an Oxaliplatin-Loaded Solid Formulation: Pharmacokinetic Properties in Rats and Nonhuman Primates and the Effects of Oral Metronomic Dosing on Colorectal Cancer
por: Pangeni R, et al.
Publicado: (2020)

Antioxidant support to ameliorate the oxaliplatin-dependent microglial alteration: morphological and molecular study
por: Jacopo J.V. Branca, et al.
Publicado: (2021)

lncRNA MCF2L-AS1/miR-105/ IL-1β Axis Regulates Colorectal Cancer Cell Oxaliplatin Resistance
por: Cai M, et al.
Publicado: (2021)

Prediction of esophagogastric varices associated with oxaliplatin administration
por: Yosuke Satta, et al.
Publicado: (2021)

DEVELOPMENT AND VALIDATION OF RP- HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF TRAMADOL HYDROCHLORIDE AND DICYCLOMINE IN BULK AND PHARMACEUTICAL FORMULATION
por: DONDA,SHAILESH T, et al.
Publicado: (2016)

SIMULTANEOUS DETERMINATION OF ENALAPRIL AND STATIN'S IN PHARMACEUTICAL FORMULATIONS BY RP-HPLC
por: SULTANA,NAJMA, et al.
Publicado: (2011)

Phytic acid potentiates oxaliplatin effects in colorectal cancer induced by 1,2-DMH: the role of miR-224 and miR-200a
por: Tarek M. Okda, et al.
Publicado: (2021)

SIMULTANEOUS ESTIMATION OF ESOMEPRAZOLE AND LEVOSULPIRIDE IN BULK AND IN CAPSULE FORMULATION BY RP-HPLC
por: JAIN,RAKESHR, et al.
Publicado: (2013)

Rational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia
por: Aerziguli Aierken, et al.
Publicado: (2021)

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF TRIFLUSAL IN BULK AND IN CAPSULE FORMULATION
por: PATIL,VIJAYK, et al.
Publicado: (2012)

SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE SODIUM PHOSPHATE IN BULK AND IN OPHTHALMIC SOLUTION BY RP- HPLC
por: DHUMAL,D. M, et al.
Publicado: (2012)

SIMULTANEOUS DETERMINATION OF LEVODROPROPIZINE, METHYLPARABEN, AND PROPYLPARABEN IN ORAL CO-FORMULATED SYRUP BY RP-HPLC METHOD
por: WESHAHY,SOHEIR ABD EL-FATAH, et al.
Publicado: (2015)

STABILITY-INDICATING RP-HPLC METHOD FOR ANALYSIS OF ATORVASTATIN IN BULK DRUG, MARKETED TABLET AND NANOEMULSION FORMULATION
por: MUSTAFA,GULAM, et al.
Publicado: (2010)

Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation
por: Pangeni R, et al.
Publicado: (2016)

SIMULTANEOUS DETERMINATION OF CEFTRIAXONE SODIUM AND STATIN DRUGS IN PHARMACEUTICAL FORMULATIONS AND HUMAN SERUM BY RP-HPLC
por: SULTANA,NAJMA, et al.
Publicado: (2010)

VALIDATED RP-HPLC METHOD FOR QUANTITATION OF GLIQUIDONE IN PHARMACEUTICAL FORMULATION AND HUMAN SERUM
por: ARAYNE,M. SAEED, et al.
Publicado: (2010)

Current Status of Breast Organoid Models
por: Srivarshini Cherukupalli Mohan, et al.
Publicado: (2021)

The p53 family member p73 in the regulation of cell stress response
por: Julian M. Rozenberg, et al.
Publicado: (2021)

Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy
por: Fan Chen, et al.
Publicado: (2021)

BOX-BEHNKEN SUPPORTED DEVELOPMENT AND VALIDATION OF ROBUST RP-HPLC METHOD: AN APPLICATION IN ESTIMATION OF PRAVASTATIN IN BULK AND PHARMACEUTICAL DOSAGE FORM
por: AHMAD,AJAZ, et al.
Publicado: (2016)

CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration via Enhancing EMT Progression
por: Zhao-wei Gao, et al.
Publicado: (2021)

Topical Delivery of Four Neuroprotective Ingredients by Ethosome-Gel: Synergistic Combination for Treatment of Oxaliplatin-Induced Peripheral Neuropathy
por: Lin HM, et al.
Publicado: (2020)

Methodologies for Generating Brain Organoids to Model Viral Pathogenesis in the CNS
por: Hannah K. Hopkins, et al.
Publicado: (2021)

Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer
por: Ping Chen, et al.
Publicado: (2021)

SOX9: Advances in Gynecological Malignancies
por: Huan Chen, et al.
Publicado: (2021)

Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes
por: Mikkel G. Terp, et al.
Publicado: (2021)

IN VITRO STUDIES OF INTERACTION BETWEEN METFORMIN AND NSAIDS (NON STEROIDAL ANTI-INFLAMATORY DRUGS) USING SPECTROPHOTOMETRY AND RP-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
por: ARAYNE,M. SAEED, et al.
Publicado: (2010)

Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic Therapy
por: Emre Küçükköse, et al.
Publicado: (2021)

New stability indicating RP-HPLC-PDA method for determination of mifepristone in bulk and tablet formulation
por: Mohammad Mojeeb Gulzar Khan, et al.
Publicado: (2021)

DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE AND FAMOTIDINE IN BULK AND TABLETS
por: DONDA,SHAILESH T, et al.
Publicado: (2014)

Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
por: Hefei Li, et al.
Publicado: (2021)

Design of a novel theranostic nanomedicine: synthesis and physicochemical properties of a biocompatible polyphosphazene–platinum(II) conjugate
por: Avaji PG, et al.
Publicado: (2016)